Hulya Ozdemir Sua Sumer Hakan Karabagli Gokhan Akdemir A Zafer Caliskaner Hasibe Artac
10.5144/0256-4947.2018.09.01.1430
Ann Saudi Med
2018 Jan-Feb;38(1):65-68.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/29313528/
Agammaglobulinemia / chemically induced Agammaglobulinemia / diagnosis Agammaglobulinemia / immunology B-Lymphocytes / drug effects B-Lymphocytes / immunology B-Lymphocytes / pathology Epilepsy / drug therapy Lymphopenia / chemically induced Lymphopenia / immunology Lymphopenia / pathology Piracetam / analogs & derivatives
Agammaglobulinemia / chemically induced Agammaglobulinemia / diagnosis Agammaglobulinemia / immunology B-Lymphocytes / drug effects B-Lymphocytes / immunology B-Lymphocytes / pathology Epilepsy / drug therapy Lymphopenia / chemically induced Lymphopenia / immunology Lymphopenia / pathology Piracetam / analogs & derivatives Case Reports Anticonvulsants / administration & dosage Anticonvulsants / adverse effects Dose-Response Relationship, Drug Epilepsy / etiology Female Humans Levetiracetam Middle Aged Piracetam / administration & dosage Piracetam / adverse effects Treatment Outcome Withholding Treatment Anticonvulsants Levetiracetam Piracetam
PMC6074184
29313528
B cell aplasia and hypogammaglobulinemia associated with levetiracetam
2018